IVME Stock Overview

A development stage company, engages in the research and development of medical devices with `near-patient' testing applications. More details

IVME fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($9K)

Latest financial reports are more than a year old

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

In Veritas Medical Diagnostics, Inc. Competitors

ThermoGenesis Holdings

OTCPK:THMO

US$11.1k

Lucira Health

OTCPK:LHDX.Q

US$4.2k

ViewRay

OTCPK:VRAY.Q

US$18.3k

Motus GI Holdings

OTCPK:MOTS

US$719.0

Price History & Performance

Summary of share price highs, lows and changes for In Veritas Medical Diagnostics
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.005
52 Week Low	US$0.0001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-66.67%
5 Year Change	-80.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	IVME	US Medical Equipment	US Market
7D	0%	-0.3%	-0.2%
1Y	n/a	11.3%	25.8%

Return vs Industry: Insufficient data to determine how IVME performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how IVME performed against the US Market.

Price Volatility

Is IVME's price volatile compared to industry and market?
IVME volatility
IVME Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.6%
10% least volatile stocks in US Market	3.1%

Stable Share Price: IVME's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine IVME's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	G. Cooper	n/a

In Veritas Medical Diagnostics, Inc., a development stage company, engages in the research and development of medical devices with `near-patient' testing applications. Its primary product includes prothrombin monitor, which is used for the measurement of coagulation of blood in patients at risk of heart disease and stroke. The company’s other products under development include predictor of labor onset, a consumer device for maternity planning; biomarker monitor for the measurement of a number of biomarkers, including heart attack, HIV, cholesterol, and cancer; blood glucose monitor, a noninvasive glucose concentration continuous bulk measuring device measurement; digital scanning machine, a noninvasive alternative to 2D X-ray scanning; osteoporosis detection and monitoring device, an instant display of bonemineral density for osteoporosis patients; and hand held digital strip reader for immunoassay applications.

In Veritas Medical Diagnostics, Inc. Fundamentals Summary

How do In Veritas Medical Diagnostics's earnings and revenue compare to its market cap?
IVME fundamental statistics
Market cap	US$8.60k
Earnings (TTM)	-US$3.13m
Revenue (TTM)	n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Is IVME overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IVME income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$3.13m
Earnings	-US$3.13m

Last Reported Earnings

Jan 31, 2008

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did IVME perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/04 07:44
End of Day Share Price	2024/12/06 00:00
Earnings	2008/01/31
Annual Earnings	2007/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

In Veritas Medical Diagnostics, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution